Clinicopathological correlates of aspartyl (asparaginyl) β-hydroxylase over-expression in cholangiocarcinoma
- 31 December 2004
- journal article
- Published by Elsevier BV in Cancer Detection Prevention
- Vol. 28 (5), 313-318
- https://doi.org/10.1016/j.cdp.2004.06.001
Abstract
Aspartyl (asparaginyl) beta-hydroxylase (AAH) expression in surgically resected intrahepatic cholangiocarcinoma significantly correlated with tumor size, growth type, differentiation, vascular invasion, and prognosis after surgery. AAH may have a role in regulating invasive or metastatic tumor cell growth of human intrahepatic cholangiocarcinoma. Recent studies demonstrated increased expression of the AAH gene in the majority of cholangiocarcinomas. The present study was undertaken to determine the relationship between high or low levels of AAH expression and the clinical course of intrahepatic cholangiocarcinoma (ICC). AAH expression was examined in 50 surgically resected primary ICCs, 12 samples of normal liver, and 12 cases of primary sclerosing cholangitis (PSC). The sections were evaluated by immunohistochemical staining with the FB-50 monoclonal antibody to human AAH protein. The sections were examined under code and graded for relative levels of AAH immunoreactivity. The results were analyzed with respect to multiple clinical and histopathological variables to determine correlates of AAH expression in ICCs. Forty-six of the 50 (92%) ICCs had AAH immunoreactivity, whereas the 12 normal liver and 12 PSC specimens were AAH negative. In the ICC specimens, the highest levels of AAH immunoreactivity were detected at the infiltrating margins that interfaced with uninvolved liver tissue, and the lowest levels occurred in the central portions of the tumors. Multivariate analysis demonstrated that high levels of AAH expression were correlated with tumor size (P < 0.05), infiltrative growth pattern (P < 0.01), aggressive histological grade (P < 0.01), vascular invasion (P < 0.05), and poor prognosis (P < 0.05). These findings suggest that AAH has an important role in regulating invasive or metastatic tumor cell growth of human ICC, and that high levels of AAH expression correlate with poor prognosis.Keywords
This publication has 19 references indexed in Scilit:
- The role of overexpression and gene amplification of cyclin D1 in intrahepatic cholangiocarcinomaJournal of Hepatology, 2001
- The role of p27kip1 protein expression on the biological behavior of intrahepatic cholangiocarcinomaHepatology, 2001
- Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinomaSurgery, 2000
- Protein expression and genetic alterations of p53 and ras in intrahepatic cholangiocarcinomaHistopathology, 1999
- The Significance of Stromal Desmoplasia in Intrahepatic CholangiocarcinomaThe American Journal of Surgical Pathology, 1999
- Does gross appearance indicate prognosis in intrahepatic cholangiocarcinoma?Journal of Surgical Oncology, 1998
- Overexpression of human aspartyl(asparaginyl)beta-hydroxylase in hepatocellular carcinoma and cholangiocarcinoma.JCI Insight, 1996
- Ki-ras mutations and p53 protein expressions in intrahepatic cholangiocarcinomas: Relation to gross tumor morphologyGastroenterology, 1995
- A fully active catalytic domain of bovine aspartyl (asparaginyl) beta-hydroxylase expressed in Escherichia coli: characterization and evidence for the identification of an active-site region in vertebrate alpha-ketoglutarate-dependent dioxygenases.Proceedings of the National Academy of Sciences of the United States of America, 1994
- Aspartyl beta-hydroxylase: in vitro hydroxylation of a synthetic peptide based on the structure of the first growth factor-like domain of human factor IX.Proceedings of the National Academy of Sciences of the United States of America, 1989